FRIDAY, DECEMBER 9, 2016

Inovio

660 West Germantown Pike Suite 110
Plymouth Meeting, PA - 19462

Inovio News

Inovio and partners make progress with MERS vaccine

Inovio Pharmaceuticals Inc. and GeneOne Life Science Inc. have partnered to create Inovio‚Äôs Middle East respiratory syndrome (MERS) vaccine, and the two companies recently announced that they have filed an Investigational New Drug Application for GLS-5300 with the U.S. Food and Drug Administration. Read More »

DNA vaccine protects non-human primates against MERS virus

Inovio's SynCon DNA-based immunotherapy platform effective in treating deadly virus. Read More »

Nancy Wysenski joins Inovio Pharmaceutical board

Nancy Wysenski recently joined the board of directors of Inovio Pharmaceuticals Read More »

DARPA provides $12.2 million to fund research on DNA-based mAbs treatments

The Defense Advanced Research Projects Agency (DARPA) funded $12.2 million for new treatments made possible through DNA-based monoclonal antibodies research. Read More »